DarioHealth Corp.

NASDAQ:DRIO

Medical - Diagnostics & Research

Healthcare
$5.13 -1.68%

-$0.12 today

Market cap
$50.27M
Beta
1.08
P/E (TTM)
5.5
EPS (TTM)
$1.26
52W Low $5.94High $17.74

Volume 0.01M

Average 0.01M

DRIO Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

DarioHealth Corp.NASDAQ: DRIO

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity falls 15.4% from a year ago

Total equity stood at $62.38M at the end of Q1 FY2026, down 15.4% from a year earlier and down 8.2% from the prior quarter. Over 3 fiscal years it compounded at -5.3% a year.

Context

  • Total equity amounted to 60.4% of total assets at the end of Q1 FY2026, down 3.4 pp from a year earlier.
  • Total equity increased in 1 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -15.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$62.38M-8.2% QoQ
Last fiscal yearDec 2025
$67.92M-5.7% YoY
Year agoMar 2025
$73.7M-15.4% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.4%——
1 year-5.7%——
3-year CAGR-5.3%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
67.92M USD
Year-over-year change
-5.7%
4-year CAGR
-5.6%

Total Equity vs competitors

How DRIO compares with its peers on the latest reported figures

  • DRIO's Mar 2026 total equity of $62.38M is the 8th highest of the 11 companies compared; the peer median is $215.43M.
  • Its year-over-year change of -15.4% is the 8th highest of 11, against a peer median of -6.9%.
  • Total equity amounts to 60.4% of total assets for DRIO, versus a peer median of 49.6%.
DRIO Competitors Peer median
Total Equity for DRIO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FLGTFulgent Genetics, Inc.Mar 2026$1.04B -7.0%-4.5%90.3%
AVNSAvanos Medical, Inc.Mar 2026$782.1M -6.8%-15.5%74.5%
OFIXOrthofix Medical Inc.Mar 2026$435.19M -5.0%+10.1%49.1%
MYGNMyriad Genetics, Inc.Mar 2026$337.4M -52.1%-25.4%50.1%
INNVInnovAge Holding Corp.Mar 2026$258.89M -3.3%-9.4%47.3%
ABSIAbsci CorporationMar 2026$171.97M -13.5%-11.6%87.9%
VSTMVerastem, Inc.Mar 2026$81.78M +352.1%+6.5%35.9%
DRIODarioHealth Corp.Mar 2026$62.38M -15.4%-5.3%60.4%
NNNNAnbio Biotechnology Class A Ordinary SharesDec 2025$30.16M +75.4%+33.9%99.7%
RGNXREGENXBIO Inc.Mar 2026$21.08M -92.3%-41.6%6.2%
PACBPacific Biosciences of California, Inc.Mar 2026$2.37M -97.4%-78.8%0.3%
Peer median (excluding DRIO) $215.43M-6.9%-10.5%49.6%

Competitors are the stored peer set for DRIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents36M49.36M36.8M27.76M26.25M
Short-term Investments000697K0
Net Receivables1.79M6.42M3.64M5.35M2.67M
Inventory6.23M7.96M5.06M4.75M4.32M
Other Current Assets0887K292K175K0
Total Current Assets45.61M65.52M47.33M40.53M34.81M
Property, Plant & Equipment (Net)989K1.99M1.87M1.77M1.27M
Goodwill41.64M41.64M41.64M57.43M57.43M
Intangible Assets12.46M9.92M5.4M18.76M15.93M
Long-term Investments20K6K6K080K
Tax Assets0(6K)000
Other Non-current Assets57K117K143K392K562K
Total Non-current Assets55.17M53.67M49.06M78.36M75.27M
Total Assets100.77M119.19M96.39M118.88M110.08M
Account Payables5.11M2.32M1.13M3.05M2.93M
Short-term Debt266K8.82M3.95M5.45M430K
Tax Payables00000
Deferred Revenue1.2M1.32M997K1.58M714K
Other Current Liabilities4.4M2.19M4.07M4.11M5.25M
Total Current Liabilities14.38M19.35M12.49M16.64M9.32M
Long-term Debt018.11M24.59M23.47M30.75M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities825K910K276K5.99M1.51M
Total Non-current Liabilities846K19.84M25.75M30.23M32.83M
Total Liabilities15.22M39.19M38.25M46.87M42.15M
Common Stock2K3K3K4K4K
Retained Earnings(222.01M)(285.85M)(349.36M)(390.34M)(452.08M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity85.55M80M58.14M72.02M67.92M
Total Debt287K28.05M29.54M30.19M31.75M
Net Debt(35.71M)(21.31M)(7.26M)2.43M5.5M

DarioHealth Corp.

NASDAQ:DRIO

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.